[1] Ma Yuanzheng, Wang Yipeng, Liu Qiang, Li Chunlin, Ma Xun,Wang Yongjun,et al. China guideline for diagnosis and treatment of senile osteoporosis (2018)[J]. Chin J Osteoporosis ,2018,24(12):1541-1567.
[2] Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009 Dec;5(12):667-76.
[4] Zhou Song, Qiu Xushneg, Zhu Zezhang, Wu Weifei, Liu Zhen,Qiu Yong. A single-nucleotide polymorphism rs708567 in the IL-17RC gene is associated with a susceptibility to and thecurve severity of adolescent idiopathic scoliosis in a Chinese Han population: a case-control study[J]. BMC Musculoskelet Disord. 2012,13:181-190.
[5] Zhou Song, Zhu Zezhang, Qiu Yong, Qiu Xusheng, Qian Bangping, Mao Saihu, et al. Association between interleukin 17 receptor C gene single nucleotide polymorphisms and adolescent idiopathic scoliosis in Han nationality [J]. Chinese Journal of Spine and Spinal Cord, 2013,23(02):161-165.
[6] Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011 Feb 25;34(2):149-62.
[7] Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012 Oct;11(10):763-76.
[8] Sieper J, Poddubnyy D, Miossec P. The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis. Nat Rev Rheumatol. 2019 Dec;15(12):747-757.
[9] Kuwabara T, Ishikawa F, Kondo M, Kakiuchi T. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases. Mediators Inflamm. 2017; 2017:3908061. doi: 10.1155/2017/3908061. Epub 2017 Feb 20.
[10] Beringer A, Miossec P. Systemic effects of IL-17 in inflammatory arthritis. Nat Rev Rheumatol. 2019 Aug;15(8):491-501.
[11] Ruiz de Morales JMG, Puig L, Daudén E, Cañete JD, Pablos JL, Martín AO, et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. Autoimmun Rev. 2020 Jan;19(1):102429.
[12] Lu Xiang, Wang Xiaochao, Lu Yumin, Jie Xuri, Huang Dan, Huang Wencai. Study on the expression of CD4+, CD25+ regulatory T cells, interleukin 17 and transforming growth factor β in peripheral blood of patients with rheumatoid arthritis [J]. Chinese General Practice. 2010,13(30):3355-3357.
[13] Lin Jinpi, Yang Bin, Ou Qishui. Study on the relationship between anti-cyclic citrullinated peptide antibody, rheumatoid factor concentration and interleukin 17mRNA expression in rheumatoid arthritis [J]. Current Immunology, 2014,34(05):377-380.
[14] DeSelm CJ, Takahata Y, Warren J, Chappel JC, Khan T, Li X, et al. IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner. J Cell Biochem. 2012 Sep;113(9):2895-902.
[16] Ho AW, Gaffen SL. IL-17RC: a partner in IL-17 signaling and beyond. Semin Immunopathol. 2010, 32:33-42.
[17] Colombini A, Lombardi G, Galliera E, Dogliotti G, Randelli P, Meerssemann A, et al. Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing. Int Orthop. 2011 May;35(5):777-82.
[18] Cappellen D, Luong-Nguyen NH, Bongiovanni S, Grenet O, Wanke C, Susa M. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. J Biol Chem. 2002 Jun 14;277(24):21971-82.